Epigenomics companies study chemical and structural changes that regulate gene activity without altering the underlying DNA sequence. Their technologies support biological research, biomarker discovery, diagnostics and the development of therapies targeting epigenetic mechanisms.
This category includes companies working on:
Browse 28 UK epigenomics companies below.
Multiomics platform for cancer biomarker discovery and diagnostics
Tagomics is a Cambridge-based biotech developing a multiomics platform for disease biomarker discovery and diagnostics. Its platform integrates genomics, epigenomics and fragmentomics with advanced bioinformatics and machine learning to identify disease-associated DNA markers from blood and other biological sources.…
Novel methylation amplification platform for clinical genomic diagnostics
Syndex Bio is a Cambridge-based biotechnology company developing a proprietary platform technology that enables amplification of DNA methylation for the first time. Unlike conventional PCR, which cannot preserve 5-methylcytosine signals, mcPCR copies both the four-base DNA code and its methylation patterns from…
Clinical-stage biotech developing treatments for multiple myeloma
CellCentric is a clinical-stage biopharmaceutical company developing inobrodib, a first-in-class oral inhibitor of the p300/CBP transcription co-activation proteins, for relapsed and refractory multiple myeloma. Inobrodib has been evaluated in over 400 patients and holds FDA Fast Track and orphan drug designations.…
Biomedical software development for genomics and medical imaging
Phenopolis is a London scientific software company developing applications and analysis pipelines for biomedical research and healthcare. Its services cover genetics, DNA methylation analysis, medical imaging, large-scale data processing and secure handling of patient information. It builds cloud and on-premises…
AI-powered cell simulation platform targeting ageing and age-driven diseases
Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary single-cell ageing clock measures epigenetic age at high throughput, feeding machine learning models that predict gene combinations and small…
Distributor of antibodies and reagents for life science research
Stratech Scientific was a UK distributor of life science research products, including antibodies, reagents, cells and specialist laboratory supplies used in immunology, cell biology, cancer research and neuroscience. On 24 February 2026, Cambridge Bioscience acquired the business. Stratech's products and customer…
Dark genome platform identifying first-in-class targets for autoimmune disease
Nucleome Therapeutics is a drug discovery company using 3D genome mapping to identify therapeutic targets encoded in the non-coding regions of the human genome. Its platform integrates high-resolution chromatin conformation data with functional genomics and machine learning to link disease-associated genetic variants…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…